Lantern Pharma, Inc. (LTRN)
3.42
-0.09
(-2.56%)
USD |
NASDAQ |
Jan 16, 16:00
3.43
+0.01
(+0.29%)
After-Hours: 20:00
Lantern Pharma EPS Diluted (Quarterly): -0.3856 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.177M |
| Total Expenses (Quarterly) | 4.177M |
| Enterprise Value | 25.98M |
| Earnings Yield | -51.25% |
| Normalized Earnings Yield | -51.25 |